The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy
MMI launch their latest solution at the AACR meeting in Chicago: CellScan
The latest technologies from ZEISS help doctors advance ophthalmic care with new ways to see pathology and maximize clinical efficiency and performance
Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate
Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer
Alexandra Knauer from KNAUER Wissenschaftliche Geräte swoops the award with her excellency in leadership and entrepreneurship
Next-generation UPLC platform designed to keep pace with evolving laboratory requirements for chromatographic performance
Bruker and Phenomenex among those recognized at new European awards ceremony held in Munich, Germany
The INVENIO™ Fourier Transform Infrared Spectrometer offers higher performance with simpler user interface
The new portable system aims to offer a robust user experience
Studies suggest that large concentrations of sulfites and bisulfites in shallow lakes may have set the stage for Earth’s first biological molecules.
The HeraSafe 2030i BSC is designed to optimize contamination control and accelerate productivity across challenging cell culture applications
Team heading to Chicago, USA, to interview scientists at the forefront of cancer research and report on the newest technologies
